Botanical species · safety record

Vicia sativa

The EFSA Compendium of Botanicals holds 13 constituent measurements and 8 adverse-effect records for Vicia sativa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Vicia sativa L.

13Constituent measurements
8Safety records
8Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Beta-cyano-l-alanine5
  • Gamma-glutamyl-beta-cyanoalanine2
  • 4-amino-butyric acid1
  • Alkaloids1
  • Cyanogenic glycosides1
  • Ethanolamine1
  • Hydrocyanic acid1
  • Vicianin1

Plant parts

  • Seed16
  • Live plants3
  • Leaves1

Preparations

  • Solvent extraction9
  • Raw, no heat treatment3

Effect types

  • Neurotoxicity3
  • Hepatotoxicity2
  • Systemic2
  • Reproductive1

Target tissues

  • Neurologic3
  • Liver2
  • Urogenital1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Beta-cyano-l-alanineSeed—0.93 PercentColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
Beta-cyano-l-alanineSeedSolvent extraction≥ 0.01 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Beta-cyano-l-alanineSeedSolvent extraction≤ 0.03 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Cyanogenic glycosidesSeedSolvent extraction—HPLC-DADResolve DOI
EthanolamineLeavesSolvent extraction6.6 Microgram/gramHPLC-DADResolve DOI
Gamma-glutamyl-beta-cyanoalanineSeedSolvent extraction≥ 0.42 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Gamma-glutamyl-beta-cyanoalanineSeedSolvent extraction≤ 0.74 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
VicianinSeed———Resolve DOI
4-amino-butyric acidSeedSolvent extraction——No resolvable identifier
AlkaloidsSeedRaw, no heat treatment—UnspecifiedNo resolvable identifier
Beta-cyano-l-alanineSeedSolvent extraction≥ 0.09 PercentUV/VIS spectroscopy (photometry)No resolvable identifier
Beta-cyano-l-alanineSeedSolvent extraction≤ 0.15 PercentUV/VIS spectroscopy (photometry)No resolvable identifier
Hydrocyanic acidSeedRaw, no heat treatment64.8 Milligram/100 gramUnspecifiedNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
ReproductiveUrogenitalLive plants—Cattle (as animal)Case reportResolve DOI
Systemic—Seed—Gallus gallus (chicken) (as animal)Short-term toxicityResolve DOI
HepatotoxicityLiverLive plants—Horse (as animal)Case reportNo resolvable identifier
HepatotoxicityLiverLive plants—Pig (as animal)Case reportNo resolvable identifier
NeurotoxicityNeurologic——Rat (as animal)Acute toxicityNo resolvable identifier
NeurotoxicityNeurologicSeed—Rhesus monkey (as animal)Not reportedNo resolvable identifier
NeurotoxicityNeurologicSeed—Duck (as animal)Not reportedNo resolvable identifier
Systemic—SeedRaw, no heat treatmentRabbit (as animal)Case reportNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Ressler, C., Tatake, JG., Kaizer, E., Putnam, DH. Neurotoxins in a vetch food: Stability to cooking and removal of gamma-glutamyl-beta-cyanoalanine and beta-cyanoalanine and acute toxicity from common vetch (Vicia sativa L) legumes . Journal of agricultural and food chemistry, 1997, vol. 45, no. 1, p. 189-194. DOI
  2. Steyn, D. G. Poisoning of human beings by weeds contained in cereals (bread poisoning). Onderstepoort journal of veterinary research, 1933, vol. 1, p. 219-66.
  3. Suter, RJ. Suspected cyanide poisoning in cows fed vetch (Vicia sativa) hay. Australian veterinary journal, 2002, vol. 80, no. 5, p. 282-282. DOI
  4. RESSLER, C. ISOLATION AND IDENTIFICATION FROM COMMON VETCH OF NEUROTOXIN BETA-CYANO-L-ALANINE, A POSSIBLE FACTOR IN NEUROLATHYRISM . Journal of biological chemistry, 1962, vol. 237, no. 3, p. 733-&.
  5. Ahn, Young Ock., Saino, Hiromichi., Mizutani, Masaharu., Shimizu, Bun-ichi., Sakata, Kanzo. Vicianin hydrolase is a novel cyanogenic beta-glycosidase specific to beta-vicianoside (6-O-alpha-l-arabinopyranosyl-beta-d-glucopyranoside) in seeds of Vicia angustifolia . Plant and cell physiology, 2007, vol. 48, no. 7, p. 938-947. DOI
  6. Berger, JD., Robertson, LD., Cocks, PS. Agricultural potential of Mediterranean grain and forage legumes: 2) Anti-nutritional factor concentrations in the genus Vicia . Genetic resources and crop evolution, 2003, vol. 50, no. 2, p. 201-212. DOI
  7. Ressler, C., Tatake, JG. Vicianin, prunasin, and beta-cyanoalanine in common vetch seed as sources of urinary thiocyanate in the rat . Journal of agricultural and food chemistry, 2001, vol. 49, no. 10, p. 5075-5080. DOI
  8. Kamo, Tsunashi., Tokuoka, Yoshinori., Miyazaki, Masahisa. Quantification of Canavanine, 2-Aminoethanol, and Cyanamide in Aphis craccivora and its Host Plants, Robinia pseudoacacia and Vicia angustifolia: Effects of These Compounds on Larval Survivorship of Harmonia axyridis . Journal of chemical ecology, 2012, vol. 38, no. 12, p. 1552-1560. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue